Ninety One North America’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Ninety One North America’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-53,371	Closed	-$5.74M	–	115
2016 Q4	$5.74M	Hold	53,371	–	–	0.86%	52
2016 Q3	$6.64M	Hold	53,371	–	–	0.89%	61
2016 Q2	$5.67M	Buy	+53,371	New	+$6.2M	0.84%	56
2015 Q1	–	Sell	-18,787	Closed	-$1.26M	–	97
2014 Q4	$1.26M	Buy	+18,787	New	+$1.16M	0.37%	49

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ninety One North America's CBPO Position: Q1 2017 in Review

Ninety One North America sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 53,371 shares — an estimated $5.74M sold.

Ninety One North America first reported a position in CBPO in Q4 2014 and held it in 4 quarters. The position peaked at $6.64M in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Ninety One North America reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Ninety One North America sold 53,371 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $5.74M.
Ninety One North America first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 4 quarters.
Ninety One North America's China Biologic Products Holdings, Inc. position peaked at $6.64M in Q3 2016.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Ninety One North America's 13F filing for Q1 2017, filed 12 May 2017.